Thomas J.  Westrick net worth and biography

Thomas Westrick Biography and Net Worth

President & CEO of GE HealthCare Technologies

Thomas Westrick has been the Vice President and Chief Quality Officer for GE Healthcare since January 2016. In this role, Tom leads the Global Quality, Medical, Regulatory Affairs, and Global Research organization. He partners with business teams across products, regions and supply chain and provides leadership to deliver product quality, reliability and compliance to all regulatory standards. Tom provides strategic direction on regulatory affairs, policy, clinical and medical matters, ensuring regulatory requirements are met and products are introduced to markets around the world efficiently and effectively.

He joined GE Healthcare in March 2003 as Global Controller and Chief Accounting Officer. In this role, Tom supported significant growth in the business including integration of over $15B in acquisitions from 2003 through 2015. He was also named Chief Risk Officer in August 2010 and was responsible for driving a comprehensive enterprise risk management program. In June 2014, he was appointed a GE officer and was given responsibility for the overall process simplification for GE Healthcare.

Prior to joining GE HealthCare, Tom spent 13 years in public accounting with Arthur Andersen LLP and Deloitte & Touche LLP in San Francisco and Milwaukee in the audit and consulting practice serving a variety of complex global companies.
Tom graduated from the University of Wisconsin-Madison with a bachelor’s degree in accounting, risk management and insurance and serves as a board member on the University of Wisconsin School of Business – Diversity Committee, The United Way of Milwaukee and the Metropolitan Milwaukee Association of Commerce.

What is Thomas J. Westrick's net worth?

The estimated net worth of Thomas J. Westrick is at least $1.38 million as of August 7th, 2024. Mr. Westrick owns 17,509 shares of GE HealthCare Technologies stock worth more than $1,381,635 as of December 21st. This net worth estimate does not reflect any other investments that Mr. Westrick may own. Learn More about Thomas J. Westrick's net worth.

How old is Thomas J. Westrick?

Mr. Westrick is currently 55 years old. There are 6 older executives and no younger executives at GE HealthCare Technologies. The oldest executive at GE HealthCare Technologies is Mr. Peter J. Arduini, President, CEO & Director, who is 59 years old. Learn More on Thomas J. Westrick's age.

How do I contact Thomas J. Westrick?

The corporate mailing address for Mr. Westrick and other GE HealthCare Technologies executives is , , . GE HealthCare Technologies can also be reached via phone at 617-443-3400 and via email at [email protected]. Learn More on Thomas J. Westrick's contact information.

Has Thomas J. Westrick been buying or selling shares of GE HealthCare Technologies?

Thomas J. Westrick has not been actively trading shares of GE HealthCare Technologies over the course of the past ninety days. Most recently, Thomas J. Westrick sold 2,750 shares of the business's stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a transaction totalling $222,145.00. Following the completion of the sale, the chief executive officer now directly owns 17,509 shares of the company's stock, valued at $1,414,377.02. Learn More on Thomas J. Westrick's trading history.

Who are GE HealthCare Technologies' active insiders?

GE HealthCare Technologies' insider roster includes H. Culp, Jr. (Director), Frank Jimenez (Insider), and Thomas Westrick (President & CEO). Learn More on GE HealthCare Technologies' active insiders.

Are insiders buying or selling shares of GE HealthCare Technologies?

In the last year, GE HealthCare Technologies insiders bought shares 1 times. They purchased a total of 1,315 shares worth more than $100,623.80. In the last year, insiders at the sold shares 5 times. They sold a total of 96,809 shares worth more than $7,900,621.05. The most recent insider tranaction occured on November, 6th when CEO Roland Rott sold 3,577 shares worth more than $309,338.96. Insiders at GE HealthCare Technologies own 0.3% of the company. Learn More about insider trades at GE HealthCare Technologies.

Information on this page was last updated on 11/6/2024.

Thomas J. Westrick Insider Trading History at GE HealthCare Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/7/2024Sell2,750$80.78$222,145.0017,509View SEC Filing Icon  
See Full Table

Thomas J. Westrick Buying and Selling Activity at GE HealthCare Technologies

This chart shows Thomas J Westrick's buying and selling at GE HealthCare Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

GE HealthCare Technologies Company Overview

GE HealthCare Technologies logo
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Read More

Today's Range

Now: $78.91
Low: $76.89
High: $79.03

50 Day Range

MA: $84.64
Low: $77.09
High: $91.62

2 Week Range

Now: $78.91
Low: $71.31
High: $94.55

Volume

11,179,275 shs

Average Volume

3,089,521 shs

Market Capitalization

$36.05 billion

P/E Ratio

21.68

Dividend Yield

0.15%

Beta

1.07